Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures
about
The role of toll like receptors in giant cell arteritisPattern recognition receptors as potential therapeutic targets in inflammatory rheumatic diseaseSynovial explant inflammatory mediator production corresponds to rheumatoid arthritis imaging hallmarks: a cross-sectional study.Toll-like receptor 2 induced angiogenesis and invasion is mediated through the Tie2 signalling pathway in rheumatoid arthritis.Designing anti-inflammatory drugs from parasitic worms: a synthetic small molecule analogue of the Acanthocheilonema viteae product ES-62 prevents development of collagen-induced arthritis.Toll-like receptors expressed by synovial fibroblasts perpetuate Th1 and th17 cell responses in rheumatoid arthritis.Fc gamma receptor IIb on GM-CSF macrophages controls immune complex mediated inhibition of inflammatory signalsProphylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasomeToll-like receptor 2 (TLR2) induces migration and invasive mechanisms in rheumatoid arthritis.Glycoprotein 96 perpetuates the persistent inflammation of rheumatoid arthritisDendritic cells provide a therapeutic target for synthetic small molecule analogues of the parasitic worm product, ES-62.The role of glycoprotein 96 in the persistent inflammation of rheumatoid arthritis.TLR2 deletion promotes arthritis through reduction of IL-10Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis.Pattern recognition receptors in equine endotoxaemia and sepsis.TLR2 & Co: a critical analysis of the complex interactions between TLR2 and coreceptors.Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics.TLRs, future potential therapeutic targets for RA.Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritis.Serum amyloid A induces interleukin-6 in dermal fibroblasts via Toll-like receptor 2, interleukin-1 receptor-associated kinase 4 and nuclear factor-κB.Synovitis biomarkers: ex vivo characterization of three biomarkers for identification of inflammatory osteoarthritis.A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease.Regulation of Inflammation and Angiogenesis in Giant Cell Arteritis by Acute-Phase Serum Amyloid A.Trapped in a vicious loop: Toll-like receptors sustain the spontaneous cytokine production by rheumatoid synovium.Hypoxia and hypoxia-inducible factor-1α provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis.TLR2 Expression in Peripheral CD4+ T Cells Promotes Th17 Response and Is Associated with Disease Aggravation of Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.Redox-mediated angiogenesis in the hypoxic joint of inflammatory arthritis.Loss of A20 in BM-MSCs regulates the Th17/Treg balance in Rheumatoid Arthritis.Association between IL-6 production in synovial explants from rheumatoid arthritis patients and clinical and imaging response to biologic treatment: A pilot study.Acute serum amyloid A is an endogenous TLR2 ligand that mediates inflammatory and angiogenic mechanismsDestructive role of myeloid differentiation factor 88 and protective role of TRIF in interleukin-17-dependent arthritis in mice
P2860
Q28069460-41A0FF00-9A62-4AD0-9F2B-4AA6364FFC2AQ28084262-F4B75711-ADD0-4884-A330-2AEC238CED57Q33832629-0F89BD70-3CB7-46AB-B400-587FE18801A0Q33999774-C9CA506F-469E-4CF3-A1BC-E6E53E7A15CDQ34016661-839DD6AC-072E-4BC1-85E3-E10463DB5377Q35189497-59059952-5CB2-4929-85DF-39529FBBE6D2Q35361098-E5ECDEB0-AF15-40AD-9B21-A6294BA21C6BQ35694891-781C73A3-D7F4-4836-A778-32CAEF242689Q35830873-51E57C1F-ADA5-4836-B337-EE79BCDB03ADQ36322915-F2C3CBB6-B8D8-479F-9C75-F0006E417858Q36368300-CE3727B2-32B4-4C62-A81C-463DE5E19339Q36572635-56278FB3-2380-4B7C-B1DD-F0E1E336E80CQ36775416-08A6D4E3-CFCC-40B8-891D-FB14E7C3B2EBQ37943809-B61AA5FD-EA92-4A7D-A0A6-4F14FF09C7D0Q38011228-3E13D0A6-C09B-4263-A44E-038E02611C89Q38132733-EC8FF551-DF86-41AD-9E64-8A5B451E9BF2Q38557048-853982E4-C663-4FE3-BB09-9B0DCF57A853Q38781354-826141AF-9F0A-4668-9C4D-49F8C445A74CQ39024059-31B74942-355E-44B3-A3C4-06DA0F65CDC6Q39029262-8B43091C-BEED-4AB8-8840-F4D8ED988AA8Q39844159-3056E386-9FEB-489D-96B5-87E22E7D20FCQ40513802-6FC28E42-5286-40D0-8F56-6B7E0CEDE9EFQ42477536-0585C733-3E71-49AC-96C4-23F2C341A101Q42790894-0832CCEA-0E42-4EA9-B28D-C937DC9D7AF4Q44003722-1C7B2449-341B-406D-97EA-2FA208A9BEB4Q45323617-54994B59-FD91-45D4-BC8A-970D5BEBC330Q46847821-00284420-5E45-4564-958B-984241A1890DQ49460237-AA099EC9-2CEA-4A0B-AC2D-9097D74DED67Q54917641-CC228D40-765C-4BAD-9433-443BBDE55700Q57232854-AF0AE9B2-4B93-4AC1-B921-60887B19E3FBQ58998287-14F8B5EA-2937-472C-B1BE-EC36D5BBE874
P2860
Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Blockade of Toll-like receptor ...... vivo synovial explant cultures
@ast
Blockade of Toll-like receptor ...... vivo synovial explant cultures
@en
type
label
Blockade of Toll-like receptor ...... vivo synovial explant cultures
@ast
Blockade of Toll-like receptor ...... vivo synovial explant cultures
@en
prefLabel
Blockade of Toll-like receptor ...... vivo synovial explant cultures
@ast
Blockade of Toll-like receptor ...... vivo synovial explant cultures
@en
P2093
P2860
P356
P1476
Blockade of Toll-like receptor ...... vivo synovial explant cultures
@en
P2093
Brian Keogh
Douglas J Veale
Jennifer McCormick
Jerome Dellacasagrande
Mary Connolly
Mary Reilly
Peter McGuirk
Sinéad Nic An Ultaigh
Tajvur P Saber
William McCormack
P2860
P2888
P356
10.1186/AR3261
P577
2011-02-23T00:00:00Z
P5875
P6179
1011364855